SkyMab Biotherapeutics
Tours
About SkyMab Biotherapeutics
SkyMab Biotherapeutics is a company that designs, develops, and engineersanti-GPCR Antibody Drug Conjugates.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Last round: Non-Equity Assistance (Jun 2019)
- Website: skymab-biotherapeutics.com
Industries & Categories
Biotechnology, Life Science, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/skymab-biotherapeutics-2760379 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.